एपीए उद्धरण

Takada, H., Kurosaki, M., Tsuchiya, K., Komiyama, Y., Itakura, J., Takahashi, Y., . . . Izumi, N. (2019). Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma. Cancers (Basel).

शिकागो स्टाइल उद्धरण

Takada, Hitomi, et al. "Baseline and Early Predictors of Good Patient Candidates for Second-Line After Sorafenib Treatment in Unresectable Hepatocellular Carcinoma." Cancers (Basel) 2019.

एमएलए उद्धरण

Takada, Hitomi, et al. "Baseline and Early Predictors of Good Patient Candidates for Second-Line After Sorafenib Treatment in Unresectable Hepatocellular Carcinoma." Cancers (Basel) 2019.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.